BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 36261794)

  • 1. Prognostic value of patient-reported outcome measures (PROMs) in adults with non-small cell Lung Cancer: a scoping review.
    Liao K; Wang T; Coomber-Moore J; Wong DC; Gomes F; Faivre-Finn C; Sperrin M; Yorke J; van der Veer SN
    BMC Cancer; 2022 Oct; 22(1):1076. PubMed ID: 36261794
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patient-reported outcome measures (PROMs) in the management of lung cancer: A systematic review.
    Bouazza YB; Chiairi I; El Kharbouchi O; De Backer L; Vanhoutte G; Janssens A; Van Meerbeeck JP
    Lung Cancer; 2017 Nov; 113():140-151. PubMed ID: 29110842
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic models for newly-diagnosed chronic lymphocytic leukaemia in adults: a systematic review and meta-analysis.
    Kreuzberger N; Damen JA; Trivella M; Estcourt LJ; Aldin A; Umlauff L; Vazquez-Montes MD; Wolff R; Moons KG; Monsef I; Foroutan F; Kreuzer KA; Skoetz N
    Cochrane Database Syst Rev; 2020 Jul; 7(7):CD012022. PubMed ID: 32735048
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene expression profiling for guiding adjuvant chemotherapy decisions in women with early breast cancer: an evidence-based and economic analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2010; 10(23):1-57. PubMed ID: 23074401
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The comparative and added prognostic value of biomarkers to the Revised Cardiac Risk Index for preoperative prediction of major adverse cardiac events and all-cause mortality in patients who undergo noncardiac surgery.
    Vernooij LM; van Klei WA; Moons KG; Takada T; van Waes J; Damen JA
    Cochrane Database Syst Rev; 2021 Dec; 12(12):CD013139. PubMed ID: 34931303
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic models for predicting relapse or recurrence of major depressive disorder in adults.
    Moriarty AS; Meader N; Snell KI; Riley RD; Paton LW; Chew-Graham CA; Gilbody S; Churchill R; Phillips RS; Ali S; McMillan D
    Cochrane Database Syst Rev; 2021 May; 5(5):CD013491. PubMed ID: 33956992
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Routine provision of feedback from patient-reported outcome measurements to healthcare providers and patients in clinical practice.
    Gibbons C; Porter I; Gonçalves-Bradley DC; Stoilov S; Ricci-Cabello I; Tsangaris E; Gangannagaripalli J; Davey A; Gibbons EJ; Kotzeva A; Evans J; van der Wees PJ; Kontopantelis E; Greenhalgh J; Bower P; Alonso J; Valderas JM
    Cochrane Database Syst Rev; 2021 Oct; 10(10):CD011589. PubMed ID: 34637526
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systematic Review of Patient-Reported Outcome Measures in Graft-versus-Host Disease.
    Kilgour JM; Wali G; Gibbons E; Scherwath A; Barata Badiella A; Peniket A; Schoemans H; Matin RN;
    Biol Blood Marrow Transplant; 2020 May; 26(5):e113-e127. PubMed ID: 32028026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Implementation of patient-reported outcome measures and patient-reported experience measures in melanoma clinical quality registries: a systematic review.
    Blood Z; Tran A; Caleo L; Saw R; Dieng M; Shackleton M; Soyer HP; Arnold C; Mann GJ; Morton RL
    BMJ Open; 2021 Feb; 11(2):e040751. PubMed ID: 33574144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Standardising the Assessment of Patient-reported Outcome Measures in Localised Prostate Cancer. A Systematic Review.
    Ratti MM; Gandaglia G; Alleva E; Leardini L; Sisca ES; Derevianko A; Furnari F; Mazzoleni Ferracini S; Beyer K; Moss C; Pellegrino F; Sorce G; Barletta F; Scuderi S; Omar MI; MacLennan S; Williamson PR; Zong J; MacLennan SJ; Mottet N; Cornford P; Aiyegbusi OL; Van Hemelrijck M; N'Dow J; Briganti A;
    Eur Urol Oncol; 2022 Apr; 5(2):153-163. PubMed ID: 34785188
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protocol for a systematic review of instruments for the assessment of quality of life and well-being in children and adolescents with cerebral palsy.
    Mpundu-Kaambwa C; Chen G; Huynh E; Russo R; Ratcliffe J
    BMJ Open; 2017 Sep; 7(9):e015924. PubMed ID: 28899888
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patient-reported outcome measures for masticatory function in adults: a systematic review.
    Fan Y; Shu X; Leung KCM; Lo ECM
    BMC Oral Health; 2021 Nov; 21(1):603. PubMed ID: 34814903
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic factors for overall survival of stage III non-small cell lung cancer patients on computed tomography: A systematic review and meta-analysis.
    van Laar M; van Amsterdam WAC; van Lindert ASR; de Jong PA; Verhoeff JJC
    Radiother Oncol; 2020 Oct; 151():152-175. PubMed ID: 32710990
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunotherapy (excluding checkpoint inhibitors) for stage I to III non-small cell lung cancer treated with surgery or radiotherapy with curative intent.
    Zhu J; Li R; Tiselius E; Roudi R; Teghararian O; Suo C; Song H
    Cochrane Database Syst Rev; 2017 Dec; 12(12):CD011300. PubMed ID: 29247502
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value of patient-reported outcome measures in adult heart-transplant patients: a systematic review.
    Villa BP; Alotaibi S; Brozzi N; Spindler KP; Navia J; Hernandez-Montfort J
    J Patient Rep Outcomes; 2022 Mar; 6(1):23. PubMed ID: 35294633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Single or combined immune checkpoint inhibitors compared to first-line platinum-based chemotherapy with or without bevacizumab for people with advanced non-small cell lung cancer.
    Ferrara R; Imbimbo M; Malouf R; Paget-Bailly S; Calais F; Marchal C; Westeel V
    Cochrane Database Syst Rev; 2020 Dec; 12(12):CD013257. PubMed ID: 33316104
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A systematic review of randomised controlled trials evaluating the use of patient-reported outcome measures (PROMs).
    Ishaque S; Karnon J; Chen G; Nair R; Salter AB
    Qual Life Res; 2019 Mar; 28(3):567-592. PubMed ID: 30284183
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quality of patient-reported outcomes used for quality of life, physical function, and functional capacity in trials of childhood fractures.
    Marson BA; Craxford S; Deshmukh SR; Grindlay DJC; Manning JC; Ollivere BJ
    Bone Joint J; 2020 Dec; 102-B(12):1599-1607. PubMed ID: 33249895
    [TBL] [Abstract][Full Text] [Related]  

  • 20. First-line treatment of advanced epidermal growth factor receptor (EGFR) mutation positive non-squamous non-small cell lung cancer.
    Greenhalgh J; Boland A; Bates V; Vecchio F; Dundar Y; Chaplin M; Green JA
    Cochrane Database Syst Rev; 2021 Mar; 3(3):CD010383. PubMed ID: 33734432
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.